sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has filed Form 8.3 regarding Mural Oncology plc. As of September 30, 2025, Vanguard holds a stake of 454,712 ordinary shares, representing 2.63% of Mural Oncology's $0.01 shares. This disclosure follows Rule 8.3 of the Irish Takeover Panel Act, 1997.
The document indicates that on September 30, Vanguard conducted a purchase of 16 shares and a sale of 191,872 shares, both at a price of 2.07 USD per share. No dealings in cash-settled or stock-settled derivatives were reported. Vanguard confirms no agreements or understandings regarding options or derivatives relating to Mural Oncology securities.
The filing confirms compliance with regulations requiring disclosure of interests exceeding 1%. No additional parties are involved, and no supplementary forms are attached to the disclosure.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.